ViaCyte   Report issue

For profit Phase 2
Founded: San Diego CA United States (1999)
Status: Acquired by Vertex (2022) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2005
NCT00260234
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Novocell | ViaCyte | ViaCyte, Inc.